Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP542064.RADUhpx-r9eUyvBeeTNNZKLqICLmx6YoQv3RcbE2H1edI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP542064.RADUhpx-r9eUyvBeeTNNZKLqICLmx6YoQv3RcbE2H1edI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP542064.RADUhpx-r9eUyvBeeTNNZKLqICLmx6YoQv3RcbE2H1edI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP542064.RADUhpx-r9eUyvBeeTNNZKLqICLmx6YoQv3RcbE2H1edI130_provenance.
- NP542064.RADUhpx-r9eUyvBeeTNNZKLqICLmx6YoQv3RcbE2H1edI130_assertion description "[Reducing RGS13 and to a lesser extent RGS1 expression in a Burkitt's lymphoma cell line enhances responsiveness to two chemokines, CXC chemokine ligand 12 (CXCL12) and CXCL13, and reducing both mRNAs augments the responses more dramatically.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542064.RADUhpx-r9eUyvBeeTNNZKLqICLmx6YoQv3RcbE2H1edI130_provenance.
- NP542064.RADUhpx-r9eUyvBeeTNNZKLqICLmx6YoQv3RcbE2H1edI130_assertion evidence source_evidence_literature NP542064.RADUhpx-r9eUyvBeeTNNZKLqICLmx6YoQv3RcbE2H1edI130_provenance.
- NP542064.RADUhpx-r9eUyvBeeTNNZKLqICLmx6YoQv3RcbE2H1edI130_assertion SIO_000772 16565322 NP542064.RADUhpx-r9eUyvBeeTNNZKLqICLmx6YoQv3RcbE2H1edI130_provenance.
- NP542064.RADUhpx-r9eUyvBeeTNNZKLqICLmx6YoQv3RcbE2H1edI130_assertion wasDerivedFrom befree-2016 NP542064.RADUhpx-r9eUyvBeeTNNZKLqICLmx6YoQv3RcbE2H1edI130_provenance.
- NP542064.RADUhpx-r9eUyvBeeTNNZKLqICLmx6YoQv3RcbE2H1edI130_assertion wasGeneratedBy ECO_0000203 NP542064.RADUhpx-r9eUyvBeeTNNZKLqICLmx6YoQv3RcbE2H1edI130_provenance.
- befree-2016 importedOn "2016-02-19" NP542064.RADUhpx-r9eUyvBeeTNNZKLqICLmx6YoQv3RcbE2H1edI130_provenance.